7 years’ experience in cancer diagnostics, stem cell research, management, business development, certificate of achievement from Harvard Medical School on cancer genetics, won several awards for her work with Carcinotech, and successfully formed a strategic partnership with Cellink to advance cancer model development through Carcinotech.
Experienced in the MedTech industry at Stryker, and as Managing Director of Orthofix. Mentor and adviser for early-stage, entrepreneurial MedTech and life sciences companies. Works with several support organisations, including Scottish Enterprise, Scottish Edge, and EIE, and is also a member of BioCity’s expert network.
Jaqueline has over 20 years’ experience in oncology clinical trials, cancer biomarkers. She is a serial entrepreneur, and currently an advisor at various institutes including IQVIA, International Cancer Genome Consortium, Cancer Therapeutics CRC and European Society of Pathology. She is also an IBITGQ Certified EU GDPR Practitioner.
Alec is Managing Director of Barwell Plc and has extensive experience of investing in start-ups and emerging technology companies with high growth potential. Alec has come on board as a financial advisor and mentor through Gabriel investors bringing his experience onboard for the financial success of Carcinotech.
Seckou has 15 years’ experience in oncology research working with cell culture and drug testing at Pfizer Inc. He then went on to complete a Ph.D. in Cancer imaging at King’s College London with imaging techniques to monitor tumor growth metastasis and response to chemotherapy. Seckou then spent 3 years working for the UCL cancer institute in microscopy and analysis of clinical samples.
Ailsa is currently doing her Ph.D. at the esteemed Optima Engineering program applying Surface Enhanced Raman Spectroscopy (SERS) to a 3D tumor on a chip model. She has a wealth of experience in engineering applications and the development of tumors on-chip devices. She is working with us alongside doing her Ph.D.
Urszula has recently finished her Ph.D. in Life sciences from Heriot-Watt with a focus on drug discovery and design. She comes with a highly experienced background in 3D assay development, drug discovery, and screening analysis, along with statistical data collection.